| Insider | Cuffe Michael S. |
|---|---|
| Title | EVP and Chief Clinical Officer |
| Transaction Date | Feb 3, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Feb 5, 2026 |
| Document Date | Feb 3, 2026 |
| Shares Sold | 1,500 |
| Price per Share | $498.09 |
| Total Value | $747,135.15 |
| Shares Owned After | 30,003 |
| Derivative | No |
| Accession Number | 0001193125-26-039795 |
| Document | View SEC Filing |